MARKET

BBH

BBH

VanEck Biotech ETF
NASDAQ
175.76
+0.66
+0.38%
Closed 16:00 07/19 EDT
OPEN
175.32
PREV CLOSE
175.10
HIGH
175.76
LOW
174.80
VOLUME
4.62K
TURNOVER
0
52 WEEK HIGH
180.00
52 WEEK LOW
142.51
TOTAL ASSET
451.52M
YTD YIELD
9.23%
1D
5D
1M
3M
1Y
5Y
1D
Biogen Earnings Preview: What to Expect
Biogen Inc. Is set to announce its fiscal Q2 earnings results before the market opens on Thursday, Aug. 1. The company is renowned for its innovative therapies for neurological and neurodegenerative diseases. Biogen reported its Q1 earnings on Apr. 24. BIIB stock is down 11.8% on a YTD.
Barchart · 3d ago
What You Need to Know Ahead of Amgen's Earnings Release
Amgen Inc. Is set to announce its fiscal Q2 earnings results after the market closes on Tuesday, Aug. 6. The company is expected to report a profit of $4.87 per share. Amgen stock is up 15.7% on a YTD basis.
Barchart · 4d ago
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 4d ago
Weekly Report: what happened at BBH last week (0708-0712)?
Weekly Report · 6d ago
Q3 2024 Equity Market Outlook
Home Market Outlook Today's Market Q3 2024 Equity Market Outlook: Neuberger Berman 2.93K Followers. We expect further corporate earnings growth across sectors, fueled by rising household net worth and a global industrial rebound. We recommend overweighting technology, communications and consumer discretionary stocks.
Seeking Alpha · 07/12 13:20
Weekly Report: what happened at BBH last week (0701-0705)?
Weekly Report · 07/08 10:37
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
Equity Outlook: Making Way For The Magnificent Others
Global stocks posted healthy gains in the first half of 2024. Despite narrow market concentration, we see opportunities in high-quality stocks that haven't yet been rewarded. With inflation still high and equity returns concentrated, the time may be right for investors to broaden their horizons. Equity Outlook: Making way for the Magnificent Others.
Seeking Alpha · 07/03 13:41
More
Profile
Fund Name
VanEck Biotech ETF
Inception Date
2011-12-20
Benchmark
MVIS US Listed Biotech 25 NR USD
Advisor Company
Van Eck Associates Corp
Custodian
State Street Bank and Trust Co
Manager
Peter Liao, Guo Hua (Jason) Jin, Griffin Driscoll